Gastrointestinal manifestations of HIV infection.
Since the beginning of the AIDS pandemic, gastrointestinal (GI) problems have been among the most common features of the disease. Despite the introduction of highly active antiretroviral therapy (HAART) in 1995 and 1996, most HIV-infected patients continue to have GI complications. The clinician must be able to diagnose and treat the opportunistic gastrointestinal infections and neoplasms that occur in the advanced AIDS patient, as well as the treatment-induced symptoms and non-HIV-related GI disorders that predominate in early HIV disease. This review addresses the GI manifestations of HIV, with particular emphasis on new developments in the era of highly effective therapy.
Wallace
M R
MR
Naval Medical Center, San Diego, CA 92134-5000, USA. mrwallace@nmcsd.navy.med.mil
Brann
O S
OS
D017088:AIDS-Related Opportunistic Infections / Q000150:complications; D015746:Abdominal Pain / Q000209:etiology; D000140:Acidosis, Lactic / Q000139:chemically induced; D023241:Antiretroviral Therapy, Highly Active; D001660:Biliary Tract Diseases / Q000821:virology; D015897:Comorbidity; D003586:Cytomegalovirus Infections / Q000150:complications; D004935:Esophageal Diseases / Q000821:virology; D004941:Esophagitis / Q000821:virology; D005767:Gastrointestinal Diseases / Q000821:virology*; D006471:Gastrointestinal Hemorrhage / Q000821:virology; D019053:HIV Enteropathy / Q000382:microbiology; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology; D006509:Hepatitis B / Q000453:epidemiology; D006526:Hepatitis C / Q000453:epidemiology; D006801:Humans; D008107:Liver Diseases / Q000821:virology; D010182:Pancreatic Diseases / Q000453:epidemiology / Q000821:virology; D011528:Protozoan Infections / Q000150:complications; D012002:Rectal Diseases / Q000821:virology; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
D018894:Reverse Transcriptase Inhibitors